Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ServiceNow, Inc. (NOW), Alibaba Group ...
We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...
StockNews.com cut shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a hold rating in a research note ...
Stock analysts at Zacks Research dropped their Q1 2025 EPS estimates for Elevance Health in a note issued to investors on Thursday, January 30th. Zacks Research analyst K. Dey now forecasts that the ...
Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...
Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.
In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...